OCT 14, 2019 2:21 PM PDT

Injectable Drug reverses symptoms of liver disease in people with HIV

WRITTEN BY: Nouran Amin

In a study conducted by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute, scientists report that an injectable hormone ‘tesamorelin’ works to reduce liver fat and prevent liver fibrosis (scarring) in HIV patients with non-alcoholic fatty liver disease, or NAFLD.

National Institute of Allergy and Infectious Disease: A microscopic image of liver tissue affected by non-alcoholic fatty liver disease (NAFLD). The large and small white spots are excess fat droplets filling liver cells (hepatocytes). Credit: Dr. David Kleiner, NCI

"Many people living with HIV have overcome significant obstacles to live longer, healthier lives, though many still experience liver disease," said NIAID Director Anthony S. Fauci, M.D. "It is encouraging that tesamorelin, a drug already approved to treat other complications of HIV, may be effective in addressing non-alcoholic fatty liver disease."

Learn more about non-alcoholic fatty liver disease, or NAFLD:

 

 

"Our hope is that this intervention may help people living with HIV, as well as benefit HIV-negative people with liver abnormalities," said Dr. Hadigan. "Further research may inform us of the potential long-term benefits of this approach and develop formulations that can benefit everyone with liver disease, regardless of HIV status."

Tesamorelin, also known as Egrifta, was approved by the U.S. Food and Drug Administration in 2010 and works to reduce excess fat around the abdomen. Findings were published in The Lancet HIV.

"Because tesamorelin proved effective in treating abnormal fat build-up in the abdomens of people in the context of HIV and related medication use, we hypothesized that the drug might also reduce fat that accrues in the liver and causes damage in a similar population," said Steven K. Grinspoon, M.D., Chief of the Metabolism Unit at MGH.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 09, 2020
Cancer
Examining a Combination Therapy Against Gastric Cancer
MAY 09, 2020
Examining a Combination Therapy Against Gastric Cancer
Often when it comes to treatments for cancer, designing or discovering new leads can take years. One of the common pract ...
MAY 29, 2020
Genetics & Genomics
Advances in Our Understanding of Huntington's Disease
MAY 29, 2020
Advances in Our Understanding of Huntington's Disease
Huntington's disease (HD) is a fatal neurodegenerative disease caused by an expanded sequence in the huntingtin gene.
JUN 01, 2020
Neuroscience
What Causes 'Good' and 'Bad' Trips in the Brain
JUN 01, 2020
What Causes 'Good' and 'Bad' Trips in the Brain
People who use psychedelics like magic mushrooms, LSD and DMT often describe a feeling of going 'beyond their human ...
JUN 14, 2020
Chemistry & Physics
Why Are There So Few Black People in STEM?
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUN 17, 2020
Drug Discovery & Development
Treating Atherosclerosis
JUN 17, 2020
Treating Atherosclerosis
The two main proponents for atherosclerotic plaque and inflammation is an increase in cholesterol and macrophage presenc ...
JUL 05, 2020
Drug Discovery & Development
New Drug May Reduce Inflammation from COVID-19
JUL 05, 2020
New Drug May Reduce Inflammation from COVID-19
Scientists from the University of Toronto have identified a new drug candidate that may reduce all kinds of inflammation ...
Loading Comments...